公开(公告)号：US10826596B2

公开(公告)日：2020-11-03

申请号：US15902784

申请日：2018-02-22

Applicant: Yash Vasavada ,  Channasandra Ravishankar ,  John Corrigan ,  Gaguk Zakaria ,  Xiaoling Huang

Inventor： Yash Vasavada ,  Channasandra Ravishankar ,  John Corrigan ,  Gaguk Zakaria ,  Xiaoling Huang

IPC: H04B7/185 ,  H04B7/204 ,  H01Q25/00

Abstract: A system and method for estimating calibration parameters and locating a Calibration Earth Station (CES) is described. The method may be performed offline. The method includes: providing L×M pilot signal measurements in a matrix R from L CESs and the M feed elements, wherein the matrix R comprises a set of channel coefficients c={c1, c2, . . . , cM}, and k={k1, k2, . . . , kL} perturbations; linking a subset of channel coefficients {c1, c2, . . . , cM} using each of the L CESs; and estimating a relative estimate of the k={k1, k2, . . . , kL} pertubations across the L CESs by using each of the L CESs as a bridging element. In the method, the bridging element provides a strong pilot signal for at least two of the L CESs. A set of criteria for determining locations of CESs have been described. A set of desirable properties for the solution set of L CESs have been disclosed. A combination of inner loop and outer loop methods for determining the final set of optimal locations have been described.

公开(公告)号：US20190068276A1

公开(公告)日：2019-02-28

申请号：US15832981

申请日：2017-12-06

Applicant: Channasandra RAVISHANKAR ,  Xiaoling HUANG ,  Nassir BENAMMAR ,  Rajeev GOPAL ,  John CORRIGAN

Inventor： Channasandra RAVISHANKAR ,  Xiaoling HUANG ,  Nassir BENAMMAR ,  Rajeev GOPAL ,  John CORRIGAN

IPC: H04B7/185 ,  H04W52/26 ,  H04L29/06

Abstract: A method for networked scheduling is disclosed. The method includes: providing a gateway; a plurality of channels assigned to a color reuse scheme including colors, wherein some of the plurality of channels assigned to one of the colors comprise a set of co-channels; associating the set of co-channels with the gateway; generating a traffic pattern for the set of co-channels for an upcoming allocation slot; determining a channel state of each co-channel in the set of co-channels per the traffic pattern; and setting a Modulation and Coding scheme (MODCOD) of each co-channel in the set of co-channels based on the respective channel state.

公开(公告)号：US20110053872A1

公开(公告)日：2011-03-03

申请号：US12810571

申请日：2009-04-01

Applicant: Quan Zhu ,  Xinghua Shi ,  Dan Tang ,  Zhaoguang Zheng ,  Bao He ,  Tingting Duan ,  Fei Gu ,  Huiquan Cheng ,  Xiaoling Huang ,  Yanxia Huang ,  Rushang Wang

Inventor： Quan Zhu ,  Xinghua Shi ,  Dan Tang ,  Zhaoguang Zheng ,  Bao He ,  Tingting Duan ,  Fei Gu ,  Huiquan Cheng ,  Xiaoling Huang ,  Yanxia Huang ,  Rushang Wang

IPC: A61K31/7048 ,  A61K31/353 ,  A61P3/10

CPC classification number: A61K31/7048 ,  A61K31/352

Abstract: The present invention relates to a pharmaceutical composition for preventing and treating diabetic complications, mainly referring to diabetic nephropathy, and the pharmaceutical composition comprises one or both of calycosin and calycosin-7-O-β-D-glucoside as 0.1˜99.5% by weight based on the total weight of the composition, and the conventional drug carrier. The pharmaceutical composition could significantly prevent and treat diabetic nephropathy, with the convenience of quality control and administration, which provides a new drug candidate for patients with diabetic nephropathy.

Abstract translation: 本发明涉及一种预防和治疗糖尿病并发症的药物组合物，主要涉及糖尿病性肾病，并且该药物组合物包含赤藓糖苷和胡萝卜素-7-O-＆bgr-D-葡萄糖苷之一或两者为0.1〜99.5％ 基于组合物的总重量和常规药物载体的重量。 药物组合物可以显着预防和治疗糖尿病肾病，方便质量控制和给药，为糖尿病肾病患者提供新的候选药物。

公开(公告)号：US20100267819A1

公开(公告)日：2010-10-21

申请号：US12823305

申请日：2010-06-25

Applicant: QUAN ZHU ,  Xinghua Shi ,  Dan Tang ,  Zhaoguang Zheng ,  Bao He ,  Tingting Duan ,  Fei Gu ,  Huiquan Cheng ,  Xiaoling Huang ,  Yanxia Huang ,  Rushang Wang

Inventor： QUAN ZHU ,  Xinghua Shi ,  Dan Tang ,  Zhaoguang Zheng ,  Bao He ,  Tingting Duan ,  Fei Gu ,  Huiquan Cheng ,  Xiaoling Huang ,  Yanxia Huang ,  Rushang Wang

IPC: A61K31/352 ,  C07D311/06 ,  A61P3/10

CPC classification number: A61K31/353 ,  A61K9/0056 ,  A61K9/2018 ,  A61K9/2027 ,  A61K9/2031 ,  A61K9/2054 ,  A61K9/2059 ,  A61K9/4875 ,  A61K31/37

Abstract: The invention relates to a pharmaceutical composition for diabetic nephropathy and its preparation, and the application in preparing of medicine for diabetic nephropathy. The pharmaceutical composition is made up of at least one of 7-hydroxycoumarin and 7-hydroxy-6-methoxycoumarin as active ingredient, and the weight percentage of active ingredient is 0.1-99.5%. Moreover, the pharmaceutical composition is mainly used for the prevention and cure of diabetic nephropathy. For the abundant material, remarkable effect on prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.

Abstract translation: 本发明涉及一种糖尿病肾病药物组合物及其制备方法及其在制备糖尿病肾病药物中的应用。 药物组合物由7-羟基香豆素和7-羟基-6-甲氧基香豆素中的至少一种作为活性成分组成，活性成分的重量百分比为0.1-99.5％。 此外，该药物组合物主要用于预防和治疗糖尿病肾病。 对于丰富的材料，对糖尿病肾病的预防和治疗效果显着，使用方便，将成为患者新的兼性药物。

公开(公告)号：US20100261787A1

公开(公告)日：2010-10-14

申请号：US12823357

申请日：2010-06-25

Applicant: Quan Zhu ,  Xinghua Shi ,  Dan Tang ,  Zhaoguang Zheng ,  Bao He ,  Tingting Duan ,  Fei Gu ,  Huiquan Cheng ,  Xiaoling Huang ,  Yanxia Huang ,  Rushang Wang

Inventor： Quan Zhu ,  Xinghua Shi ,  Dan Tang ,  Zhaoguang Zheng ,  Bao He ,  Tingting Duan ,  Fei Gu ,  Huiquan Cheng ,  Xiaoling Huang ,  Yanxia Huang ,  Rushang Wang

IPC: A61K31/27 ,  A61P3/10 ,  A61P13/12

CPC classification number: A61K31/27 ,  A61K9/0056 ,  A61K9/2018 ,  A61K9/2027 ,  A61K9/2031 ,  A61K9/2054 ,  A61K9/2059 ,  A61K9/4875

Abstract: The invention relates to application of 4,4′-diphenylmethane-bis(methyl)carbamates (DPMC) extracted and isolated from Cortex Mori and preparation of medicine for diabetic nephropathy. The pharmaceutical composition is made up of DPMC as active ingredient and the normal drug carriers, and the weight percentage of active ingredient is 0.1-99.5%. For the remarkable effect of prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.

Abstract translation: 本发明涉及从Cortex Mori提取分离的4,4'-二苯基甲烷 - 双（甲基）氨基甲酸酯（DPMC）的应用和糖尿病性肾病药物的制备。 药物组合物由作为活性成分的DPMC和正常药物载体组成，活性成分的重量百分比为0.1-99.5％。 为了预防和治疗糖尿病肾病和使用便利性的显着效果，它将成为患者的新的兼性药物。